DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/sscvq8/global_breast) has announced the addition of the "Global Breast Cancer Monoclonal Antibodies Market Outlook 2020" report to their offering. Globally, Roche seems to dominate the breast cancer monoclonal antibody segment because of largest inventory. Its block buster molecule, Herceptin has been able to dominate this segment for several years. It was found that breast cancer cells become recalcitrant
| < Prev | Next > |
|---|
